This inventor holds 3 USPTO granted patents. Top assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1976-1977.
Company Filing History:
Years Active: 1976-1977
Title: Mutsuo Kataoka: Innovator in Hypertension Treatment
Introduction
Mutsuo Kataoka is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hypertension. With a total of 3 patents to his name, Kataoka's work has the potential to impact the lives of many individuals suffering from this condition.
Latest Patents
Kataoka's latest patents include a method and composition for treating hypertension. This involves new compounds that inhibit the enzyme activities of tyrosine hydroxylase and dopamine β-hydroxylase, making them useful chemotherapeutic agents. Another patent features a series of 2-hydrocinnamoyl-1,3-cyclopentanedione derivatives, which have been found to have hypotensive properties. These compounds can be synthesized through specific chemical reactions, showcasing Kataoka's innovative approach to drug development.
Career Highlights
Kataoka is associated with Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, where he continues to advance his research in medicinal chemistry. His work is characterized by a focus on developing new therapeutic agents that can effectively manage hypertension.
Collaborations
Throughout his career, Kataoka has collaborated with esteemed colleagues such as Masaji Ohno and Norio Kawabe. These partnerships have likely contributed to the depth and breadth of his research endeavors.
Conclusion
Mutsuo Kataoka's contributions to hypertension treatment through innovative compounds highlight his role as a significant inventor in the pharmaceutical industry. His ongoing research promises to enhance therapeutic options for patients worldwide.